CSBR Champions Oncology Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CSBR

Price (delayed)

$5.13

Market cap

$69.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.72

Enterprise value

$73.01M

Champions Oncology is a data-driven research organization that leverages an oncology research center of excellence to develop transformative technology and accelerate oncology research and development. This technology ranges from computational-based ...

Highlights
The debt fell by 13% YoY and by 3.8% QoQ
Champions Oncology's equity has shrunk by 129% YoY
CSBR's quick ratio is down by 41% year-on-year and by 11% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.championsoncology.com
Peers: CRL EXEL CLDX

Key stats

What are the main financial stats of CSBR
Market
Shares outstanding
13.59M
Market cap
$69.74M
Enterprise value
$73.01M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.48
Earnings
Revenue
$49.22M
EBIT
-$9.66M
EBITDA
-$7.67M
Free cash flow
-$6.72M
Per share
EPS
-$0.72
Free cash flow per share
-$0.49
Book value per share
-$0.15
Revenue per share
$3.62
TBVPS
$1.95
Balance sheet
Total assets
$26.79M
Total liabilities
$28.85M
Debt
$7.74M
Equity
-$2.06M
Working capital
-$8.77M
Liquidity
Debt to equity
-3.76
Current ratio
0.6
Quick ratio
0.56
Net debt/EBITDA
-0.43
Margins
EBITDA margin
-15.6%
Gross margin
40.1%
Net margin
-19.8%
Operating margin
-19.5%
Efficiency
Return on assets
-32.6%
Return on equity
-850.7%
Return on invested capital
-94.9%
Return on capital employed
-200.5%
Return on sales
-19.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CSBR stock price

How has the Champions Oncology stock price performed over time
Intraday
4.69%
1 week
0.79%
1 month
6.65%
1 year
1.79%
YTD
-8.72%
QTD
4.48%

Financial performance

How have Champions Oncology's revenue and profit performed over time
Revenue
$49.22M
Gross profit
$19.74M
Operating income
-$9.61M
Net income
-$9.73M
Gross margin
40.1%
Net margin
-19.8%
The company's gross profit fell by 22% YoY and by 4.4% QoQ
CSBR's gross margin is down by 15% year-on-year and by 2.9% since the previous quarter
The revenue has contracted by 8% YoY
The net margin fell by 2.6% QoQ

Growth

What is Champions Oncology's growth rate over time

Valuation

What is Champions Oncology stock price valuation
P/E
N/A
P/B
N/A
P/S
1.42
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.48
Champions Oncology's equity has shrunk by 129% YoY
The price to sales (P/S) is 41% lower than the 5-year quarterly average of 2.4 and 5% lower than the last 4 quarters average of 1.5
The revenue has contracted by 8% YoY

Efficiency

How efficient is Champions Oncology business performance
The company's return on invested capital fell by 12% QoQ
The ROA has contracted by 9% from the previous quarter
The company's return on sales fell by 2.6% QoQ

Dividends

What is CSBR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CSBR.

Financial health

How did Champions Oncology financials performed over time
The total assets is 7% smaller than the total liabilities
CSBR's quick ratio is down by 41% year-on-year and by 11% since the previous quarter
Champions Oncology's current ratio has decreased by 39% YoY and by 10% QoQ
Champions Oncology's equity has shrunk by 129% YoY
The debt to equity has plunged by 104% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.